Skip to main content
Log in

Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The Acne-Specific Quality of Life Questionnaire (Acne-QoL) was developed to measure the impact of facial acne across four dimensions of patient quality of life. The main objective of the current study was to evaluate the responsiveness of this instrument. Secondarily, this study provided an opportunity to extend the developer's psychometric validation. The Acne-QoL was utilized in two randomized, double-blind, placebo-controlled studies of the efficacy of Estrostep® (norethindrone acetate/ethinyl estradiol) in the treatment of facial acne; a total of 296 Estrostep® and 295 placebo patients were evaluated. The Acne-QoL was completed at the beginning, middle (cycle 3), and end (cycle 6) of the 6-month treatment period. The responsiveness of the Acne-QoL was demonstrated through its ability to detect both small (baseline to mid-study) and moderate (baseline to study end) treatment advantages for Estrostep® patients. Confirmatory factor analysis supported the subscale structure, and internal consistency estimates were excellent. Convergent and discriminant validity were supported by correlations between Acne-QoL scores and clinical measures that were both in the direction and relative magnitude hypothesized. Finally, item response theory analyses confirmed that each item is highly related to its subscale's latent construct and that each subscale is sensitive across a broad range of the underlying continuum. The results of this evaluation confirm that the Acne-QoL is responsive, internally consistent, and valid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bergfeld WF. The evaluation and management of acne: Economic considerations. J Am Acad Dermatol 1995; 32: S52–S56.

    Google Scholar 

  2. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxietyand depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25–32.

    Google Scholar 

  3. Gupta MA, Gupta AK, Schork NJ, Ellis CN, Voorhees JJ. Psychiatric aspects of the treatment of mild to moderate facial acne. Int J Dermatol 1990; 29: 719–721.

    Google Scholar 

  4. Koo J. The psychosocial impact of acne: Patient's perceptions. J Am Acad Dermatol 1995; 32: S26–S30.

    Google Scholar 

  5. Lydick E, Yawn, BP. Clinical interpretation of healthrelated qualityof life data. In: Staquet MJ, Hays RD, Fayers PM (eds), Quality of Life Assessment in Clinical Trials. New York: Oxford University Press, 1998, 299–314.

    Google Scholar 

  6. Girman CJ, Hartmaier S, Thiboutout D, et al. Evaluating health-related qualityof life in patients with facial acne: Development of a self-administered questionnaire for clinical trials. Qual Life Res 1996; 5: 481–490.

    Google Scholar 

  7. Merck and Co., Inc. Acne-Specific Qualityof Life Questionnaire (Acne-QoL): Manual and Interpretation Guide. Whitehouse Station, NJ: Merck and Co., Inc., 1997.

    Google Scholar 

  8. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutout D, Girman CJ. Health related qualityof life among patients with facial acne: Assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001; 26: 380–385.

    Google Scholar 

  9. Maloney JM, Arbit DI, Flack M, McLaughlin-Miley CJ, Sevilla C, Derman R. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol (Estrostep®) in the treatment of moderate acne vulgaris. Clin J Women's Health 2001; 1: 123–131.

    Google Scholar 

  10. Guyatt GH, Walter SD, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 171–178.

    Google Scholar 

  11. Jöreskog KG, Sörbom D. LISREL® 8: User's Reference Guide. Chicago, Illinois: Scientific Software International, Inc., 1996.

    Google Scholar 

  12. Schumacker RE, Lomax RG. A Beginner's Guide to Structural Equation Modeling. Mahwah, NJ: Erlbaum, 1996.

    Google Scholar 

  13. Samejima F. Estimation of latent abilityusing a response pattern of graded scores. Psychometric Monograph, 1969, no. 17.

  14. Thissen D. MULTILOGTM User's Guide: Version 6.0. Chicago, Illinois: Scientific Software International, Inc., 1991.

    Google Scholar 

  15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977; 8.

    Google Scholar 

  16. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 2nd ed. New York: Oxford University Press, 1995; 65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S.E. Fehnel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fehnel, S., McLeod, L., Brandman, J. et al. Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res 11, 809–816 (2002). https://doi.org/10.1023/A:1020880005846

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020880005846

Navigation